Your Primer to Healthcare Mergers and Acquisitions

Author: Alan J. Hymowitz

Exit Planning
Selling a C Corporation: Key Tax Implications You Should Understand

Depending on your healthcare company's corporation type, there are different tax implications you will want to be aware of long before you are ready to sell your business. One type of company that brings with it tax implications that often catch owners off-guard or create challenges when owners are ready to pursue a transaction is C corporations (C-corp).

Read More
Healthcare Sectors, Valuation
Understanding and Valuing a Freestanding Emergency Department

Freestanding emergency departments (FSED) have seen substantial growth over the past two decades. Research published in the Western Journal of Emergency Medicine states that the National Emergency Department Inventory determined in 2001 that about 1% of all emergency departments (ED) in the United States were FSEDs. Fast forward to 2016 and the Medicare Payment Advisory Commission reported that FSEDs had accounted for 11% of all EDs nationwide. Grand View Research is projecting that the U.S. FSED market size, which was valued at around $3 billion in 2019, is expected to expand at a compound annual growth rate (CAGR) of around 5% from 2020-2027.

Read More
Healthcare Sectors, Market Trends, Valuation
Retail Pharmacy Update: Opportunities, Challenges, and Valuations

Prior to the pandemic, the retail pharmacy industry was experiencing significant disruption. We were witnessing a steady increase in transactions and consolidation, Amazon's entry into the market, significant changes to strategic alliances between major payers and pharmacy benefit managers (PBMs), and the introduction of a wide array of new technologies, just to name a few noteworthy trends and developments. It's safe to say that COVID-19 not only disrupted some of these disruptors, but it also brought with it new disruptors.

Read More
Market Trends
5 Reasons 2021 Will Be a Very Big Year for Healthcare Transactions

Each year typically brings at least some unforeseen developments that influence healthcare transactions. Oftentimes, these occurrences affect a single sector or just a few sectors. Rarely, if ever, is there an unexpected event that touches numerous marketplaces, let alone all of them, and does so in a dramatic way.

Read More
Healthcare Sectors, Market Trends
8 Pharmacy Trends From 2020 That Are Here To Stay

As we approach the end of year, it's a good time to look back and identify some of the more significant pharmaceutical developments from 2020 that are playing a role in influencing or reshaping the industry. Here are eight noteworthy trends that emerged or gained steam this year that are likely to follow us into 2021 and beyond.

Read More
Exit Planning, Market Trends
Completing an M&A Deal in the COVID-19 Era: What You Need to Know

Pre-COVID-19, a merger and acquisition (M&A) deal that followed an 80/10/10 structure was fairly common. In such in a transaction, up to 80% of a company's purchase price would be afforded to the seller as an upfront, cash proceed, at least 10% of the company's purchase price would be in the form of rollover equity, and at least 10% of the company's purchase price would be in the form of deferred proceeds (e.g., an earn-out or seller note).

Read More
Healthcare Sectors, Market Trends
7 Noteworthy Coronavirus News Developments for Pharmacies

While all of healthcare has been hit hard by the rapid spread of the novel coronavirus, some industries have been affected more than others. Much of the news has focused on the impact to those facilities providing care to clients and patients, such as nursing homes, senior living, hospitals, and urgent care centers, there's another industry that's been greatly impacted but is under the radar: pharmacy.

Read More
Healthcare Sectors
Fall of Diplomat Pharmacy: 10 Things That Went Wrong

In July 2015, Diplomat Pharmacy was the talk of the town. Momentum seemed like it was on the company's side, with Diplomat looking poised to be a major player for many years to come. But, as it is often said, "the higher they rise, the harder they fall." In December 2019, UnitedHealth Group's OptumRx agreed to acquire Diplomat for about $4 a share in cash. What caused this "All-American success story" to come up so short on expectations?

Read More
Healthcare Sectors
What I'm Listening for at the National Association of Specialty Pharmacy Meeting

What are the current developments concerning specialty pharmacies? Alan Hymowitz takes a closer look at five key areas.

Read More
Healthcare Sectors, Market Trends
Trends in Retail Pharmacy: 8 Numbers to Know

This article examines some of the key trends, developments and disruptions in the retail pharmacy. Here are eight statistics and figures that help paint a clearer picture of where the industry is now and where it may be heading.

Read More
Exit Planning, Healthcare Sectors, Market Trends
Why You Should Sell Your Business In 2019 (Part 1)

Consolidation in healthcare picked up steam in 2018 and shows no signs of slowing down in 2019. This trend, along with other factors, is placing great pressure on providers of healthcare services to address a critical question: Is this the year to sell?

For many providers, the answer should be simple: yes.

In this first in a two-part series, two of our Managing Directors speak to why pharmacies and intellectual or developmental disabilities (IDD) service providers should sell in 2019.

Read More
Healthcare Sectors, Valuation
What's The Value Of Your Independent Pharmacy (Part 2)?

As we indicated in our recent article, “What’s The Value Of Your Independent Pharmacy (Part 1)?,” the market for independent pharmacies continues a very dynamic run. Private equity, strategic consolidators, and other investors are looking to add scale and locations, whether special needs/long-term care (LTC), retail, home infusion, compounding, nuclear, or hospice pharmacy.

Numerous factors have contributed to the strength of the “perfect storm” in the pharmacy marketplace and include...

Read More

Committed to Constant Improvement?

Subscribe to our bi-weekly newsletter – SalientValue

No Spam Ever. We Promise.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram